Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
103.9 USD | -1.59% |
|
-0.15% | +12.61% |
Kurzporträt
Mitarbeiterzahl: 645
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Precision Therapies
100,0
%
| 204 | 100,0 % | 249 | 100,0 % | +22.22% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
91,1
%
| 190 | 93,3 % | 227 | 91,1 % | +19.38% |
Rest of World
8,9
%
| 14 | 6,7 % | 22 | 8,9 % | +61.52% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 05.01.16 |
Alexis Borisy
FOU | Founder | 52 | 01.10.08 |
Director of Finance/CFO | 52 | 01.09.14 | |
Jeffrey Albers
CHM | Chairman | 52 | 24.07.14 |
Janet Loesberg
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.03.20 |
Becker Hewes
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.05.20 |
Percy Carter
CTO | Chief Tech/Sci/R&D Officer | 53 | 19.05.21 |
Christina Rossi
COO | Chief Operating Officer | 48 | 29.10.18 |
Chief Tech/Sci/R&D Officer | 61 | 10.10.17 | |
Tracey McCain
CMP | Compliance Officer | 56 | 06.09.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 14.04.16 |
Alexis Borisy
FOU | Founder | 52 | 01.10.08 |
Lonnel Coats
BRD | Director/Board Member | 58 | 04.02.16 |
Nicholas Lydon
FOU | Founder | 67 | 01.10.08 |
Mark Goldberg
BRD | Director/Board Member | 69 | 25.06.15 |
Daniella Beckman
BRD | Director/Board Member | 45 | 08.12.21 |
Jeffrey Albers
CHM | Chairman | 52 | 24.07.14 |
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 05.01.16 |
Habib Dable
BRD | Director/Board Member | 54 | 23.06.22 |
John Tsai
BRD | Director/Board Member | 57 | 06.01.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 62 616 902 | 62 062 451 ( 99,11 %) | 0 | 99,11 % |
Unternehmenskontakt
Blueprint Medicines Corp.
45 Sidney Street
02139, Cambridge
+617 374 7580
http://www.blueprintmedicines.com![Straße Blueprint Medicines Corporation(BPMC)](https://cdn.zonebourse.com/static/address/22033569.png)
Sektor
Umsatz je Region
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+12.61% | 6.5 Mrd. | |
+38.66% | 52.85 Mrd. | |
+35.45% | 38.24 Mrd. | |
-7.81% | 38.87 Mrd. | |
-10.77% | 26.79 Mrd. | |
+11.77% | 26.16 Mrd. | |
-17.82% | 19.9 Mrd. | |
+35.09% | 13.18 Mrd. | |
+29.17% | 12.24 Mrd. | |
-3.05% | 11.79 Mrd. |
- Börse
- Aktien
- A14SDD Aktie
- Unternehmen Blueprint Medicines Corporation